בוקולאם 2.5 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

MIDAZOLAM AS HYDROCHLORIDE 2.5 MG

MAH:

NEOPHARM CURE (2005) LTD

ATC_code:

N05CD08

pharmaceutical_form:

OROMUCOSAL SOLUTION

administration_route:

BUCCAL

manufactured_by:

SCM PHARMA LIMITED, UK

therapeutic_group:

MIDAZOLAM

therapeutic_indication:

Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

authorization_date:

2013-05-01